ArabFinance: Consumer healthcare company Integrated Diagnostics Holdings is currently considering a potential dual listing of its ordinary shares on the Egyptian Exchange (EGX), according to a November 17th press release.

The move would be complementary to its trading on the London Stock Exchange, aiming to benefit from a wider base of potential investors, the company remarked.

IDH also intends to improve its liquidity and enhance trading volumes with growing participation from local retail and institutional investors, according to the statement.

The firm operates in Egypt, Jordan, Sudan, and Nigeria, IDH noted.

“If IDH was to pursue the dual listing, the Group is fully committed to meeting the high standards of disclosure expected of companies listed in Egypt as well as in London," the company’s CEO Hend el Sherbini commented.

The EGX would see another listing over the coming period, as Prime FinTech has revealed a plan to float its shares.